NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT02374931 2019-10-0318F-FES PET/CT in Imaging Patients With Desmoid TumorsVanderbilt-Ingram Cancer CenterPhase EARLY_PHASE1 Terminated3 enrolled